BioMarin investing $43M in fill-finish line at plant in Ireland

BioMarin's plant in Ireland is the first outside the U.S. for the genetic disease specialist. (BioMarin)

BioMarin had its first manufacturing site outside of the U.S. approved just last year. But the genetic disease specialist is already expanding the site in Ireland and adding dozens of new jobs.

The drugmaker will invest about $43 million in a filling line at the bulk biologics plant in Shanbally, County Cork, and is expected to bring on 51 employees as a result, according to an announcement from the Ireland Development Agency.